Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage

[1]  G. Qiao,et al.  The baroreflex afferent pathway plays a critical role in H2S-mediated autonomic control of blood pressure regulation under physiological and hypertensive conditions , 2020, Acta Pharmacologica Sinica.

[2]  M. Brainin,et al.  Tracking the global burden of stoke and dementia: World Stroke Day 2020 , 2020, International journal of stroke : official journal of the International Stroke Society.

[3]  Jia-guo Zhou,et al.  Reduced intracellular chloride concentration impairs angiogenesis by inhibiting oxidative stress-mediated VEGFR2 activation , 2020, Acta Pharmacologica Sinica.

[4]  L. Tao,et al.  GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function , 2020, Acta Pharmacologica Sinica.

[5]  Dorairaj Prabhakaran,et al.  2020 International Society of Hypertension global hypertension practice guidelines. , 2020, Journal of hypertension.

[6]  Dorairaj Prabhakaran,et al.  2020 International Society of Hypertension Global Hypertension Practice Guidelines. , 2020, Hypertension.

[7]  F. Takeuchi,et al.  LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1) Deletion Has Protective Effects on Stroke in the Genetic Background of Stroke-Prone Spontaneously Hypertensive Rat , 2020, Stroke.

[8]  C. Miao,et al.  Metrnl deficiency decreases blood HDL cholesterol and increases blood triglyceride , 2020, Acta Pharmacologica Sinica.

[9]  Dong-sheng Wang,et al.  Aggravated ulcerative colitis caused by intestinal Metrnl deficiency is associated with reduced autophagy in epithelial cells , 2020, Acta Pharmacologica Sinica.

[10]  Fares Alahdab,et al.  Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[11]  Y. Dong,et al.  Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension , 2019, Medicine.

[12]  S. Yusuf,et al.  Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study , 2016, The Lancet.

[13]  Kalyan C. Tirupula,et al.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli , 2015, Pharmacological Reviews.

[14]  Y. Li,et al.  A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk , 2015, PloS one.

[15]  W. Koch,et al.  Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison , 2015, Scientific Reports.

[16]  C. Miao,et al.  Extracellular Visfatin has Nicotinamide Phosphoribosyltransferase Enzymatic Activity and is Neuroprotective Against Ischemic Injury , 2014, CNS neuroscience & therapeutics.

[17]  Z. Pei,et al.  Stroke-prone renovascular hypertensive rat as an animal model for stroke studies: From artery to brain , 2013, Journal of the Neurological Sciences.

[18]  Junwen Qiao,et al.  A 26-week repeated-dose toxicity study of allisartan isoproxil in Sprague-Dawley rats , 2013, Drug and chemical toxicology.

[19]  A. Dorrance,et al.  The effects of hypertension on the cerebral circulation. , 2013, American journal of physiology. Heart and circulatory physiology.

[20]  Cheng Huang,et al.  Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats , 2012, Acta Pharmacologica Sinica.

[21]  Y. Zhou,et al.  Posterior cerebral artery-posterior communicating artery (PCA-PComA) aneurysms: report of five cases and literature review. , 2012, Neurology India.

[22]  P. Vanhoutte,et al.  Visfatin and Cardio–Cerebro–Vascular Disease , 2012, Journal of cardiovascular pharmacology.

[23]  C. Bai,et al.  Blood Pressure Reduction Combining Baroreflex Restoration for Stroke Prevention in Hypertension in Rats , 2010, Front. Pharm..

[24]  L. Lindholm,et al.  Stroke and blood-pressure variation: new permutations on an old theme , 2010, The Lancet.

[25]  Yukio Hosokawa.  Effects of angiotensin receptor blocker and calcium channel blocker on experimental abdominal aortic aneurysms in a hamster model. , 2010, The Kurume medical journal.

[26]  D. Su,et al.  Effects of allisartan, a new AT1 receptor blocker, on blood pressure and end-organ damage in hypertensive animals , 2009, Acta Pharmacologica Sinica.

[27]  D. Su,et al.  PRESSOR AND NON‐PRESSOR EFFECTS OF SODIUM LOADING ON STROKE IN STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS , 2008, Clinical and experimental pharmacology & physiology.

[28]  D. Su,et al.  Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats , 2007, Acta Pharmacologica Sinica.

[29]  Chunli Liu,et al.  dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP , 2007, Journal of the Neurological Sciences.

[30]  Hong Zhao,et al.  Effect of telmisartan on expression of protein kinase C-α in kidneys of diabetic mice , 2007, Acta Pharmacologica Sinica.

[31]  Xiu-Juan Ma,et al.  Arterial Baroreflex: A Novel Target for Preventing Stroke in Rat Hypertension , 2007, Stroke.

[32]  Nicoletta Pellegrini,et al.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[33]  D. Su,et al.  Reduction of blood pressure variability: a new strategy for the treatment of hypertension. , 2005, Trends in pharmacological sciences.

[34]  D. Su,et al.  Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats , 2005, Journal of hypertension.

[35]  D. Sica,et al.  Clinical Pharmacokinetics of Losartan , 2005, Clinical pharmacokinetics.

[36]  D. Su,et al.  Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats. , 2004, Acta pharmacologica Sinica.

[37]  M. Fujishima,et al.  Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension , 2004, Virchows Archiv A.

[38]  Hong Chen,et al.  Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats. , 2003, Acta pharmacologica Sinica.

[39]  A. Cowley,et al.  Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  D. Su,et al.  Comparative study of sinoaortic denervated rats and spontaneously hypertensive rats. , 2003, American journal of hypertension.

[41]  D. Su,et al.  The importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervation , 2002, Journal of hypertension.

[42]  A. Zou,et al.  Oxidative stress enhances the production and actions of adenosine in the kidney. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[43]  F. Rey,et al.  Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2− and Systolic Blood Pressure in Mice , 2001, Circulation research.

[44]  R. Huang,et al.  Stroke-prone renovascular hypertensive rats. , 1998, Chinese medical journal.

[45]  Y. Zhang,et al.  Two-kidney, two clip renovascular hypertensive rats can be used as stroke-prone rats. , 1998, Stroke.

[46]  E. Johns,et al.  The effect of angiotensin II receptor antagonists on kidney function in two-kidney, two-clip Goldblatt hypertensive rats. , 1997, European journal of pharmacology.

[47]  D. Su,et al.  [Antihypertensive effects of atenolol and nitrendipine alone or in combination on three hypertensive models of rats]. , 1992, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[48]  C. Barrès,et al.  Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. , 1986, The American journal of physiology.

[49]  M. Serio,et al.  Radioimmunoassay of plasma aldosterone. , 1974, The Journal of nuclear biology and medicine.

[50]  C. A. Nugent,et al.  A radioimmunoassay for plasma aldosterone. , 1970, The Journal of clinical endocrinology and metabolism.